The challenges in diagnosing pediatric primary antiphospholipid syndrome

Demir S., Keskin A., Sag E., Akca U. K., Atalay E., Kasap Cüceoğlu M., ...Daha Fazla

LUPUS, cilt.31, sa.10, ss.1269-1275, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 10
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1177/09612033221108853
  • Dergi Adı: LUPUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1269-1275
  • Anahtar Kelimeler: Pediatric Antiphospholipid Syndrome, Primary Antiphospholipid Syndrome, Nonthrombotic Manifestations in Antiphospholipid Syndrome, INTERNATIONAL CONSENSUS STATEMENT, SYSTEMIC-LUPUS-ERYTHEMATOSUS, CLASSIFICATION CRITERIA, ANTIBODY PROFILES, CHOREA
  • Eskişehir Osmangazi Üniversitesi Adresli: Hayır

Özet

Pediatric primary antiphospholipid syndrome (APS) is a very rare disease with significant distinctions from the APS in adults. Herein, we present our experience in the diagnosis and treatment of six pediatric primary APS patients, who met the updated Sapporo criteria for the APS diagnosis. One of them was also diagnosed as having probable catastrophic APS (CAPS) due to the involvement of three different organ systems simultaneously. Besides vascular involvement, four patients had thrombocytopenia, one had psychiatric disorder, and one had chorea and valvular heart disease. All patients received immunosuppressive treatment along with long-term anticoagulation therapy. Specific neurologic and hematologic manifestations that are not part of the classification criteria can be seen in children with primary APS. Therefore, using the adult criteria for diagnosing pediatric APS may result in missed or delayed diagnoses in children.